Clinical Trial Update: A Study to Assess the Effect of SB 659032 on Platelet Function [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the effect of SB 659032 on platelet function in patients with atherosclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Drugs mentioned

• SB 659032

Snippet

Sponsor: GlaxoSmithKline | Conditions: Atherosclerosis | Phase 1 | Status: COMPLETED